Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States.

Carlyne M AverellFrançois LalibertéGuillaume GermainMei Sheng DuhMatthew D RousculpSean D MacKnightDavid J Slade

Published in: Therapeutic advances in respiratory disease (2022)

This real-world study highlights the short-term clinical and economic benefits of ICS/LABA adherence in asthma, particularly in reducing severe exacerbations.

Keyphrases

chronic obstructive pulmonary disease
lung function
cystic fibrosis
allergic rhinitis
glycemic control
early onset
type diabetes
metabolic syndrome
combination therapy
adipose tissue
drug induced